Primary Care Clinics in Ball, LA Accepting Medicare
8 Primary Care Clinics found. Showing 1 - 8
 Verna Family Medicine Family Medicine Medicare: Medicare Enrolled Practice Location: 6118 Monroe Hwy, Ball, LA 71405 Phone: 318-640-4949 Fax: 318-640-4962 |
Winn Community Health Center, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 5010 Monroe Hwy, Ball, LA 71405 Phone: 318-648-0375 |
Transitional Care Concepts, Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 5609 Monroe Hwy, Ball, LA 71405 Phone: 318-419-8937 |
Winn Community Health Center, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 4310 Pardue Rd, Ball, LA 71405 Phone: 318-648-0375 |
Tioga High Sbhc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1207 Tioga Rd, Ball, LA 71405 Phone: 866-530-6111 |
Tioga Jr High Sbhc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1150 Tioga Rd, Ball, LA 71405 Phone: 866-530-6111 |
Winn Community Health Center, Inc. Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 89 Camp Livingston Rd, Ball, LA 71405 Phone: 318-648-0375 |
Devinder K. Verma M.d. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6118 Monroe Hwy Ste B, Ball, LA 71405 Phone: 318-640-7366 Fax: 318-640-7466 |
News Archive
New findings hold promising implications for blindness caused by limbal stem cell deficiency
Researchers at the University of Oslo have made discoveries that can have great consequences for the treatment of blindness caused by so-called limbal stem cell deficiency.
GTRI researchers to test the affect of RFID systems on implantable and wearable medical devices
Radio frequency identification (RFID) systems are widely used for applications that include inventory management, package tracking, toll collection, passport identification and airport luggage security. More recently, these systems have found their way into medical environments to track patients, equipment assets and staff members.
Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study
Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year (2) study will assess the impact of genetic information in calculating doses and the changes in the rate of adverse events when initiating Warfarin drug therapy. These changes will be compared against doses initiated without genetic data. The randomized and blinded, multi-center study will involve more than 7000 participants at over 50 sites nationwide.
Viewpoints: Pres. Obama on debt deal, Medicare; Sen. Barasso on insurance future; Pundits on compromise
For years now, America has been spending more money than we take in. The result is that we have too much debt on our nation's credit card — debt that will ultimately weaken our economy, lead to higher interest rates for all Americans, and leave us unable to invest in things like education, or protect vital programs like Medicare.
Courtagen launches nucSEEKPDx assay
Courtagen Life Sciences, Inc., a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced the expansion of their genetic test menu. The new genetic test, nucSEEKPDx, will sequence approximately 1,100 nuclear genes constituting the mitochondrial exome, which encodes the vast majority of proteins found in the mitochondrion. This test is by far the most comprehensive test on the market for the management of mitochondrial disorders.
› Verified 3 days ago